Clinical trial
Comparison of the Performance of SB2-Infliximab With Originator Infliximab in the Measure of Serum Concentrations in Serum
NCT03308357 is registered in ClinicalTrials.gov with The Alfred as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Comparison of the Performance of SB2-Infliximab With Originator Infliximab in the Measure of Serum Concentrations in Serum
- Lead sponsor
- The Alfred
- Phase
- Observational
- Overall status
- Unknown status
- Start date
- October 31, 2017
- Completion date
- March 31, 2018
- Enrollment
- 6 (estimated)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.